T1	Premise 1 144	During the last decade, survival rates for breast cancer have increased as a result of earlier detection and increased use of adjuvant therapy.
T3	Premise 1185 1331	Among all treatment groups, patients who had a mastectomy had the poorest physical functioning at registration (P<.001) and at enrollment (P=.05).
T4	Premise 1332 1461	At enrollment, mood and emotional functioning were similar among all patients, with no differences by type of treatment received.
T5	Premise 1462 1750	At enrollment, symptoms, including muscle stiffness, breast sensitivity, aches and pains, tendency to take naps, and difficulty concentrating, were common among patients in all groups and were statistically significantly associated with poor physical functioning and emotional well-being.
T6	Premise 1751 1883	Sexual functioning was worse for women who received chemotherapy than for those who did not, regardless of type of surgery (P<.001).
T7	Claim 1884 2113	At the end of primary treatment for breast cancer, women in all treatment groups report good emotional functioning but report decreased physical functioning, particularly among women who have a mastectomy or receive chemotherapy.
T8	Claim 2114 2307	Clinical interventions to address common symptoms associated with treatment should be considered to improve physical and emotional functioning at the end of primary treatment for breast cancer.
R1	Support Arg1:T3 Arg2:T7	
R2	Support Arg1:T5 Arg2:T7	
R3	Support Arg1:T4 Arg2:T7	
